The study authors said they aimed to develop a robust and safe Crispr-Cas regimen, striving for an inclusive HIV cure for all that can inactivate diverse HIV strains across various cellular contexts.
Trending
- Pate sets up emergency task force on diphtheria outbreak
- Otti raises alarm over cancer, stroke in Abia youths
- Orile Agege hospital targets 3,000 children in back-to-school outreach
- NMA urges FG to implement 65-year retirement for clinical workers
- IFAD-VCDP calls for land rights for women farmers
- Kwara community gets free medical checkups
- Cancer treatment should never stop, FG says
- Nigeria moves to strengthen forest sector
